FDA Delays Approval Of Moderna Jab For Kids As More Safety Concerns Emerge

Moderna says FDA told co it needs “additional time to evaluate recent international analyses of the risk of myocarditis after vaccination,” review of #covid19 vaccine for age 12-17 may take until Jan 2022. Moderna will delay filing for 6-11 as a result https://t.co/7UBeeQOtI7

— Meg Tirrell (@megtirrell) October 31, 2021

• FDA Delays Approval Of Moderna Jab For Kids As More Safety Concerns Emerge
  by Tyler Durden, https://www.zerohedge.com/
  Once again, regulators are having concerns about the safety of the Moderna COVID jab, particularly among young patients, following data released over the summer which suggested that the Moderna jab might be even more dangerous to younger patients than its top rival, the Pfizer jab. Safety studies on both vaccines carried out by Canadian researchers found that the Moderna jab might be as much as 2.5x higher than the dangers of side effects from the Moderna jab.
  –
  After the FDA and CDC ignored the advice from their respective advisory panels and went ahead with offering emergency use approvals for both jabs and the J&J jab for younger patients, But now, the FDA is re-examining its decision to authorize the Moderna COVID jab for adolescents as young as 12 years old. Specifically, the agency is examining the potentiality for dangerous heart inflammation in a certain group of younger patients, who are at a higher risk of side effects.
  –
  The FDA has decided to delay its approval for the Moderna jab for patients between the ages of 12 to 17 – a decision that comes just three days after the FDA authorized the Pfizer-BioNTech’s COVID-19 vaccine or children between ages five and 11.
  –
  read more.

end